Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

News

Article

September 21, 2015

Marianne Davies on Immunotherapy-Related Side Effects in Lung Cancer

Author(s):

Marianne Davies

Key Takeaways

  • Immunotherapy has transformed lung cancer treatment but introduces unique side effects affecting multiple organ systems, requiring careful monitoring and management.
  • Early recognition and intervention of immunotherapy-related toxicities are crucial to prevent complications and optimize patient outcomes.
  • Multidisciplinary collaboration is essential for effectively managing immunotherapy side effects, ensuring comprehensive patient care.
  • Oncologists must understand the spectrum of immunotherapy-related toxicities and management strategies to enhance patient safety and treatment efficacy.
SHOW MORE

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
image of man.
Dr. Joshua Sabari and Chris Conneran
Picture of Dr. John Oertle
Related Content
Advertisement
clinical trial logo
September 16th 2025

Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

Spencer Feldman
cancer horizons podcast logo: a white microphone on a blue background
September 16th 2025

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
illustration of lungs
September 16th 2025

Tepmetko Associated With Frequent Side Effects for Some With NSCLC

Jax DiEugenio
CURE Cancer Horizons logo
September 16th 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
September 16th 2025

Standing Up to Cancer: What it Means to Me

Tamron Little
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses: © stock.adobe.com.
September 16th 2025

THIO Plus Libtayo Elicits Positive Responses in Advanced NSCLC

Alex Biese
Related Content
Advertisement
clinical trial logo
September 16th 2025

Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

Spencer Feldman
cancer horizons podcast logo: a white microphone on a blue background
September 16th 2025

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
illustration of lungs
September 16th 2025

Tepmetko Associated With Frequent Side Effects for Some With NSCLC

Jax DiEugenio
CURE Cancer Horizons logo
September 16th 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
September 16th 2025

Standing Up to Cancer: What it Means to Me

Tamron Little
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses: © stock.adobe.com.
September 16th 2025

THIO Plus Libtayo Elicits Positive Responses in Advanced NSCLC

Alex Biese
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.